BUFFERIN Safety Questions, BUFFERIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about BUFFERIN. Our extensive database of BUFFERIN adverse events and BUFFERIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about BUFFERIN
BUFFERIN Safety Reports
Total BUFFERIN reports: 24.BUFFERIN FDA safety alerts: No.
Reported hospitalizations: 13.
Take BUFFERIN Side Effects Survey or Share Your BUFFERIN Story. Read More Here.
Physician from JAPAN reported BUFFERIN problem on Jan 24, 2007. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. BUFFERIN dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Consumer or non-health professional from JAPAN on Feb 21, 2007. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, cardiac failure congestive, dilatation ventricular, dyspnoea, ejection fraction decreased, pulmonary congestion. BUFFERIN dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL, VALSARTAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from JAPAN reported BUFFERIN problem on Mar 06, 2007. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, brain natriuretic peptide increased, cardiac failure congestive, cardiac murmur, dilatation ventricular. BUFFERIN dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Apr 23, 2007. Female patient, 53 years of age, was diagnosed with nasopharyngitis and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. BUFFERIN dosage: unknown. During the same period patient was treated with ALPINY SUPPOSITORIES. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported BUFFERIN problem on June 05, 2007. Male patient was diagnosed with cerebrovascular accident and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: anaemia, colon cancer, haemoglobin decreased, rectal haemorrhage. BUFFERIN dosage: unknown. During the same period patient was treated with ASPIRIN, PLAVIX. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on June 27, 2007. Male patient, 56 years of age, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: atelectasis, chest pain, haemorrhagic anaemia, haemothorax, iatrogenic injury, musculoskeletal pain, procedural complication, prothrombin time prolonged. BUFFERIN dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported BUFFERIN problem on June 06, 2006. Male patient, 74 years of age, was diagnosed with angina pectoris, stomach discomfort and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: liver disorder. BUFFERIN dosage: unknown. During the same period patient was treated with PEPCID RPD, PANALDINE, NITOROL, ISOSORBIDE MONONITRATE. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Feb 06, 2006. Male patient, 56 years of age, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: feeling hot, henoch-schonlein purpura, leukocytoclastic vasculitis, oedema. BUFFERIN dosage: unknown. During the same period patient was treated with PANALDINE, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM HYDRATE, BEZAFIBRATE. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported BUFFERIN problem on Oct 10, 2006. Male patient, 32 years of age, was diagnosed with respiratory tract infection and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: brain oedema, hepatic function abnormal, hyperammonaemia, restlessness, reye's syndrome, status epilepticus. BUFFERIN dosage: unknown. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Physician from JAPAN on Nov 21, 2006. Male patient, 77 years of age, was diagnosed with diabetes mellitus, hypertension and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, catheterisation cardiac, chest x-ray abnormal, interstitial lung disease, pyrexia. BUFFERIN dosage: unknown. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN. Patient recovered.
Physician from JAPAN reported BUFFERIN problem on Nov 21, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. BUFFERIN dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Dec 11, 2006. Male patient, 65 years of age, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: cyanosis, duodenal ulcer haemorrhage, fat embolism, pyrexia, renal failure acute. BUFFERIN dosage: unknown. During the same period patient was treated with TICLOPIDINE, WARFARIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported BUFFERIN problem on Nov 21, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. BUFFERIN dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.
BUFFERIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 06, 2007. Male patient, weighting 191.8 lb, was diagnosed with cerebrovascular accident and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, rectal cancer, rectal haemorrhage. BUFFERIN dosage: unknown. During the same period patient was treated with ASPIRIN, PLAVIX. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported BUFFERIN problem on Sept 20, 2007. Female patient, weighting 2.36 lb, was diagnosed with antiphospholipid syndrome and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: antiphospholipid antibodies positive, caesarean section, premature baby, premature separation of placenta, protein s decreased. BUFFERIN dosage: unknown. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Sept 20, 2007. Female patient, 30 years of age, was diagnosed with antiphospholipid syndrome and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: premature baby, premature separation of placenta. BUFFERIN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported BUFFERIN problem on Sept 20, 2007. Female patient, 28 years of age, was diagnosed with antiphospholipid syndrome and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: haematoma. BUFFERIN dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Sept 19, 2007. Female patient, 45 years of age, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: haematoma, premature labour. BUFFERIN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported BUFFERIN problem on Sept 19, 2007. Female patient, 45 years of age, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: haematoma, platelet count increased, pregnancy induced hypertension, premature labour. BUFFERIN dosage: unknown. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Sept 19, 2007. Female patient, 54 years of age, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: placenta accreta, placenta praevia. BUFFERIN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported BUFFERIN problem on Sept 20, 2007. Female patient, 28 years of age, was diagnosed with antiphospholipid syndrome and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: antepartum haemorrhage. BUFFERIN dosage: unknown. During the same period patient was treated with HEPARIN. Patient recovered.
BUFFERIN problem was reported by a Health Professional from JAPAN on Sept 20, 2007. Female patient, 30 years of age, was diagnosed with antiphospholipid syndrome and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: premature baby, premature separation of placenta. BUFFERIN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported BUFFERIN problem on Sept 20, 2007. Female patient, weighting 2.36 lb, was diagnosed with antiphospholipid syndrome and was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: premature baby. BUFFERIN dosage: unknown. Patient recovered.
BUFFERIN problem was reported by a Consumer or non-health professional from BRAZIL on Sept 11, 2007. Female patient, 76 years of age, weighting 180.8 lb, was treated with BUFFERIN. After drug was administered, patient experienced the following problems/side effects: dizziness, fall, lower limb fracture, pain in extremity, syncope, walking aid user. BUFFERIN dosage: unknown. During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE, LEXOTAN, GALVUS MET, GLUCOFORMIN. Patient was hospitalized. Patient recovered.